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BackgrouTld. Predilection sire for the acute myocardial ill/arclion of the right ven-
tricle, (AMI-RV) is the upper third ofthe rig/II corollary artery and for this reason
sitch an infarction is followed by numerous complications, primarily by conduction
disorders and very often by suddell and rapid cardiogenic shock developme1lf.
Methods. Primary percwafleolls trans/uminal coronary oll8ioplasry (PPTCA) was
performed 011 three patiellts, ill whom the acllfe infarction ofthe right \'ell(ricular \Vas
diagnosed and who had been hospitalized six hours after the beginning 0/chest pain.
/n all three patiellls ill(racoronary stell( was implanted. 0" the admission potiell(s had
been in the threatening cardiogenic shock, with the prominent chest pain and with the
elevation oj ST-segmelll in V4R>2 mV. /n the course of i"ten1entioll patients were
administered low-molecular intracoronary heparin, witli direct platelet glycoprotein
lib/II/a illhibitors (abciximab), according to the established procedure applied ill such
cases. Results. The complete dilatation ofthe inJarcted artery lVas established with tile
signs 0/ reperfusion alld the further clinical course was completely nonnal. there was
no heart Jail//re and patients had 110 sI/bjectil'e difficulties. Conclusion. Invasive
approach in the trealmem ofAMI-RV is justifiable. alld possibly the therapy ojchoice
a/these patients, providing well trained andequipped team is available.
Key words: myocardial infarction; ventricular disfunction, right;
angioplasty, transluminal, percutaneous coronary;
coronary vessels; stenls; platelet aggregation
inhibitors; heparin, low.molecular.weight; platelet
glycoprotein GpUb·lIIa complex.
Introduction
The goal of the current therapy of myocardial infarclion
of the right ventricle (AMI·RV) is rapid, and if possible,
complete patency achievement of the infarction artery in or-
der to reduce the size of necro~is,establish the reperfusion of
the affected area and at the same time prevent other possible
complications, and reduce mortality rdte (I, 2). The extensive
necrosis is affecting inferoposterior segment of the right ven·
tricle associated with the infarction extension to the free wall
of the right ventricle (RV), distal half of interventricular sep-
IUm. papillary muscles. valvular apparatus with cardiac con-
dUClioll system. Owing (0 these facts prognosis and early
clinical course within the first 24 hours are quite uncertain.
and the mortality rale is from 20 do 50% (3-5). Parallel wilh
fibrinolytic therapy administration, there is a growing interest
for mechanical reperfusion by using primary or delayed (life
saving or rescue) balloon dilatation (6-8).
Three patients with the diagnosed AMJ-RV associated
wilh inferoposterior infarction of the left ventricle in whom
specific treatmenl protocol and primary percutaneous trans-
luminal coronary angioplasty (PPTCA) were applied are pres-
sented in (his paper. On the admission. patients recived aspirin
300 mg peroraly together with the combination of intracoro·
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intracoronary low-molecular heparin (enoxaparin 20 mg) and
intravenous unfracuoned heparin 5000 intravenous (Lv.) im-
mediately before angioplasty. All patients received abcixi-
mab, glycoprotein UbJUla inhibitor 10 mg before and 10 mg
after the stent implantation into the right coronary anery. The
therapy wall continued with enoxaparin I mglkg subcu-
tanously (s.c.) every 12 hours and with 10 mg ofabciximab in
Lv. infusion during the first 12 hours after the performed
PPTCA.
Case reports
l. Female patient, 60 years ofage. first infarction: on
the admission there was a slow atrial fibrilation with ven-
tricular response 60/min, logetner with the signs of infero-
posterior infarction of the right ventricle. Blood pressure
was 80/40 mmHg. Risk factors were smoking and the in-
creased cholesterol level. Ultrasound of the hean performed
immediately after admission showed dilated right ventricle
associated with tricuspid failure and RV pressure of 40
mmHg. Three hours after the onset of AMI-RV. PPTCA
and intracoronary stent implantation were performed. ECG
taken immediately after PPTCA showed the rapid resolution
of ST segment for more than 70% with the early formation
of the negative T-wave (signs of the early mechanical reper-
fusion). Control echocardiography before discharging still
showed dilated right ventricle and RV pressure was still 40
mmHg. After the discharge clinical finding was normal and
there were no subjective difficulties during the four months
follow-up period.
Fig. I) ECG on the admission. Fig. 2) ECG right-sided
leads. Fig. 3) Before and after the dilatation (PPTCA). Fig.
4) ECG immediately after the dilatation. Fig. 5) ECG right-
sided leads after the dilatation.
Fig. 1 - ECG on the admission.
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Fig. 2 - ECG right-sided leads.
Fig. 3 - Before and after the dilatation (PPTCA)....
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Fig. 4- ECG immediately afIer the dilatation.
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Fig. 5 - ECG righi-sided leads afIer the dilatation.
2. Female, 69 years of age, first infarction: on the ad-
mission sinus bradycardia was 55/min, AV block grade U
O
(MobilZ II), and there were signs of inferoposterior infarc-
tion of the right ventricle. Blood pressure was 80/40. Risk
factors were smoking and the increased cholesterol level.
Ultrasound of the heart on the admission showed dilated
right ventricle, tricuspid regurgitation 2+ and RV pressure
higher than 30 mmHg. PPTCA was performed two hours af-
ter the infarction and due to the dissection of Lhe right coro-
nary artery intima 3 imracoronary stems were implanted
suecessefuly. Echocardiography finding before the dis-
charge estimated ejection fraction (EF):50%, with the infe-
rior wall hypokinesis and normal RV. Clinical findings
were nonnal, and after being discharged from the hospital
the paticm was without subjective difficulties within Lhe
three months follow-up period.
Fig. 6) ECG on the admission. Fig. 7) ECG right-sided
leads. Fig. 8) High stenosis of the RCA. Fig. 9) Coronaro-
graphy after PPTCA with 3 scents in aseries.
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Fig. 7 - ECG right-sided leads
Fig. 8 - High stenosis of the RCA
3. Male, 77 years of age, first infarction: on the ad-
mission, sinus rhythm, heart rale 70/min., AV block was 1°,
with signs of inferopostcrior infarction of the right ventri-
cle. Blood prcssure was 120nO. Risk faclOrs were periph-
eral arterial disease (intcrrniuem claudication of the lower
leg), diabetes type 2, and stable angina pectoris. Six hours
after the onset of chest pain PPTCA of the right coronary
artery was performed and intracoronary slcnt was im-
planted. The patient also had the complete left anterior de-
Fig. 9 - Coronarography after PPTCA with 3 stems in aseries
scendent (LAD) occlusion. Cardial ullrasound finding be-
fore the discharge showed EF 45%, akinesia of the medial
and apical segment of inferior wall together with hypokine-
sis of inferior segment of the lateral wall and RV of normal
dimensions. After being discharged, patient'S clinical find-
ings were nonnal and without subjective diflicuhies during
the three months follow-up period.
Fig. 10) ECG on the admission. Fig. II) Dilatation of
RCA with the stcnt implanta[ion.
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Fig. 11 - Dilatation ofRCA with the sten! implamalion.
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Discussion
Paticllls with combined myocardial infarction of the
lert and right ventricle generally require complex therapy:
volume replacing. in order La increase the reduced minute
volume, fibrinolytic or PPTCA therapy in combination with
anliaggrcgatory and anlieoagulam Iherapy, or delayed
?TeA and imracoronary SlenL FirSl communications on
sueeessrul application or PPTCA in pallellls with AMI-RV
and rapid hacrnodynamic recovery of lhe patient previously
being in cardiogcnic shock indicated a new era of illlcrvcn-
lional cardiology in the treatment of these patiems (9). A
greal number of following studies dealing with the problem
or PPTCA or the delayed PTCA in the treatmelll or the
acute myocardial infarction cited that In about 90% of pa~
ticnts the maximum blood now (TlMI-J) through the in-
farcled anery was achieved after the balloon dilatation, giv~
ing much better results in comparison wiLh the common in-
travenous fibrinolytic therapy (10-12).
The results of an extensive randomized study GUSTO
Ilb by comparing erreclS or the accelerated protocol with Lis-
sue~typc plasminogen activalor and PPTCA showed that me-
chanical reperfusion had reduced mortalily rale for 33% in
AMJ and in serious cerebrovascular accidents during the first
30 days or the hospital treatmenl. However, during the rol-
lowing 4 monLhs the pereemage or the engaged .nery
restenosis was even 45%, which significamly diminished the
efficiency or this metllOd ortreatment (13).
For this reason modified PPTCA was introduced and
direct glycoprotein inhibitors (abciximab) in combination
wilh antiaggrcgation agents and low-molecular heparin
were included into the Iherapeutic protocol. A great number
of foHowing studies, as well as several randomized ones,
showed thai thcrapy modified in this way and administered
within the first 12 hours from the onsel of AMI reduced the
mortality rate, myocardial reinfarction, urgent revasculari-
zation and postinfarction angina for 48% in comparison
with the patients underwent PTeA, but without glycopro-
tein inhibitors (J 4, 15).
This is the first rcpon in our medical hterature or the
successrul lrC3lJnem or AMI-RV by PPTCA in combination
with abciximab and low~molccular weight heparin together
with intracoronary Slent implanlation in all 3 patients and is in
accordance with ACClAI-IA recommendations (16). Patients
who displayed the threatening cardiogenie shock confirmed
by ECG, with eonduclion disorders in the rorm or AV block
grade IO_mo and who Came within the first 6 hours rrom the
onset of AMI~RV were urgClllly selll to catheterizalion room
due to lheir serious condition. where pacemaker wa.~ im~
plamed and urgent coronarography with PPTCA was per~
romled in the same act. Rapid clinical recovery, ST clevation
regression ror more than 50% within the first 6 hours arler the
intervention and the maximum increase of cardiospecific en-
zymes within lhe first 12 hours from the onset of AMI con~
vincingly confirmed ravourable clinical course. TIle SPECf
performed within two weeks after the intervention confirmed
sueeessrul rcperrusion in the area or the inrareted artery. Only
in one case cchocardiographic finding showed slower course
of the right ventricle recovery with persisting tricuspid failure
and right ventricle pressure of40 mmHg, bUI all other clinical
indicators were nonnal.
Our experience in lhe treallnel1l of patients with PPTCA
was also confirmed by other studies which undoubtedly up-
holded our altitude that invasive approach wilh urgent
coronarography was the only hope ror survival or thesc pa-
tients and Lhat it should be performed whenever possible, if
personnel and technical equipment are provided (17-20).
Conclusion
Patients with AMI~RV represent a subgroup with the
very high risk within the scope of inferoposlerior engaging
or the left ventricle with numerous and hardly predictable
complications resulting in high mortality ralC. Our initial
experience in the treatment of these patients by PPTCA
complelely confirmed that this thernpcutic approach was
absolutely justifiable in patients with cardiogenic shock, if
there were comraindications for fibrinolytic therapy. or ifCrpaHa 86 BOJIIOCAIII1TETCKH nPErJ1Eil 6poj I
the optimal period of 6 hours after the onset of infarction
had passed. Complete recovery of our paticnrs and their
normal clinical course within the first three months after be-
ing discharged from Ihe hospilal showed Ihal Ihe invasive
approach in Ihe Irealmem of AMI-RV was juslifiable and
the possible therapy of choice of these paticnls. providing
both trained personnel, including a (cam of inrcrvenlional
cardiologists. and technical equipment.
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PRIMARNA PERKUTANA TRANSLUMINALNA KORONARNA ANGIOPLASTIKA U
AKUTNOM INFARKTU DESNE KOMORE
Uvod. Predilekeijsko mesto za nastanak akutnog interkta miokarda desne komore
(AIM-DK) je gornja treeina desne koronarne arterije, zbog cega je ovakav in/arkt
praeen mnogobrojnim komplikaeijama, u prvom redu poremeeajima sprovodenja i
cesto naglim i brzim razvojem kardiogenog ~oka. Melode. Primarna perkutana
Iransluminalna koronarna angioplastika (PPTKA) uradena je kod Iri bolesnika kod
kojih je dokazan akutni intarkt desne komore (AIM-DK), a koji su primljeni na
bolnicko lecenje u prvih ~est sati od pocetka anginoznih bolova i sva Iri bolesnika
su dobila inlrakoronarni stent. Pri prijemu, bolesniei su ispoljavali simptome
preleeeg kardiogenog soka, sa izrazenim anginoznim bolovima i elevaeijom ST-
segmenta u V,R veeom od 2 mV. U loku interveneije svi su dobili niskomolekulski
heparin intrakoronarno uz direktni inhibitor glikoproteina tromboerta lib/lila
(abeiksimab), prema ustaljenom protokolu koji primenjujemo u takvim
slucajevima. Rezullali. Postignula je potpuna dilataeija zahvaeene arterije uz
znake reperfuzije i dalji klinicki tok je prosao potpuno normalno, a u daljem
pracenju u sledeea tri meseea po izlasku iz balnice, bolesnici su kardijalno
kompenzovani i bez ikakvih subjektivnih legoba. lakliucak: Invazivni pristup
lecenju AIM-DK je opravdana i moguca terapija izbora za ove bolesnike, pod
uslovom da je sprovodi dobro obucen i opremljen tim.
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